Precision BioSciences (DTIL) Competitors

FitLife Brands (NASDAQ:FTLF) and Precision BioSciences (NASDAQ:DTIL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings, valuation and community ranking.

Does the media refer more to FTLF or DTIL?

In the previous week, FitLife Brands and FitLife Brands both had 1 articles in the media. Precision BioSciences' average media sentiment score of 1.32 beat FitLife Brands' score of 0.95 indicating that Precision BioSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FitLife Brands	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Precision BioSciences	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer FTLF or DTIL?

FitLife Brands currently has a consensus price target of $40.00, suggesting a potential upside of 27.23%. Precision BioSciences has a consensus price target of $39.50, suggesting a potential upside of 736.86%. Given Precision BioSciences' higher possible upside, analysts plainly believe Precision BioSciences is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Precision BioSciences	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community favor FTLF or DTIL?

Precision BioSciences received 88 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 67.67% of users gave Precision BioSciences an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote.

Company	Underperform	Outperform
FitLife Brands	Outperform Votes 2 50.00%	Underperform Votes 2 50.00%
Precision BioSciences	Outperform Votes 90 67.67%	Underperform Votes 43 32.33%

Which has better valuation & earnings, FTLF or DTIL?

FitLife Brands has higher earnings, but lower revenue than Precision BioSciences. FitLife Brands is trading at a lower price-to-earnings ratio than Precision BioSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$62.76M	2.30	$5.30M	$1.69	18.60
Precision BioSciences	$75.10M	0.48	-$61.32M	$0.06	78.67

Which has more risk & volatility, FTLF or DTIL?

FitLife Brands has a beta of 0.96, meaning that its share price is 4% less volatile than the S&P 500. Comparatively, Precision BioSciences has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500.

Do insiders & institutionals believe in FTLF or DTIL?

2.3% of FitLife Brands shares are owned by institutional investors. Comparatively, 38.0% of Precision BioSciences shares are owned by institutional investors. 61.3% of FitLife Brands shares are owned by company insiders. Comparatively, 4.0% of Precision BioSciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Is FTLF or DTIL more profitable?

FitLife Brands has a net margin of 13.38% compared to Precision BioSciences' net margin of 11.48%. FitLife Brands' return on equity of 28.03% beat Precision BioSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	13.38%	28.03%	15.13%
Precision BioSciences	11.48%	-23.69%	-6.98%

Summary

FitLife Brands and Precision BioSciences tied by winning 9 of the 18 factors compared between the two stocks.